Patents for A61K 49 - Preparations for testing in vivo (35,376)
07/2004
07/08/2004US20040132064 Ratios of collagen peptides, their uses and products
07/08/2004US20040132058 NPC1L1 (NPC3) and methods of use thereof
07/08/2004US20040131551 Chelate compounds; magnetic resonance imaging
07/08/2004US20040131550 Bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands
07/08/2004US20040131549 Contrast agents
07/08/2004US20040131548 Ultrasonic diagnosis; microbubbles of gas encapsulated in polymer
07/08/2004US20040131547 Contrast agents
07/08/2004US20040131546 Micelle forming concentration; controlling particle sizes;galolinium complex
07/08/2004US20040129581 Barium swallowing kit
07/08/2004US20040129082 Method for improved measurement of local physical parameters in a fluid-filled cavity
07/08/2004DE19744003B4 Kontrastmittel für das Infarkt- und Nekroseimaging Contrast agents for infarction and necrosis
07/08/2004DE10252390A1 Verfahren zur Bestimmung der Funktionsfähigkeit der Bauchspeicheldrüse Methods for determining the functionality of the pancreas
07/08/2004CA2508276A1 Neuroprotective activity of activated protein c is independent of its anticoagulant activity
07/07/2004EP1434768A1 Enhanced substrate imaging by reversible binding to a paramagnetic complex
07/07/2004EP1434604A2 4-haloethenylphenyl tropane:serotonin transporter imaging agents
07/07/2004EP1434571A1 Particle immobilized coatings and uses thereof
07/07/2004EP0825851B1 Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof
07/07/2004CN1511046A Diagnosis marker
07/07/2004CN1511045A Monitoring marker
07/07/2004CN1156445C Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isindoline derivatives
07/06/2004US6759517 Allergenic proteins of natural rubber latex, their production and use in assays
07/06/2004US6759406 Quaternary ammonium compounds
07/06/2004US6759387 Delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue
07/06/2004US6759038 Evaluating drug for prevention of cancer propagation; administer drug to vertebrate, monitor cancer propagation by fluoresence, compare to control, decrease in fluoresence indicates prevention of tumor propagation
07/06/2004US6759028 Treating arteriovenous malformations by use of radioactive compositions; in vivo delivery of radioactive compositions which are delivered as a fluid to one or more vascular sites and solidified
07/01/2004WO2004054637A2 Contrast media formulations having improved biological tolerance
07/01/2004WO2004054623A1 Magnetic resonance imaging method and compounds for use in the method
07/01/2004WO2004038381A3 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
07/01/2004WO2004028551A9 Novel agents that modulate eph receptor activity
07/01/2004WO2004026111A3 Flexible and/or elastic brachytherapy seed or strand
07/01/2004WO2004017905A3 Method and apparatus for noninvasively evaluating endothelial function
07/01/2004WO2004013161A3 Peptide aggregates
07/01/2004WO2003051278A3 Nanoparticle delivery vehicle
07/01/2004US20040127696 Growth differentiation factor-7
07/01/2004US20040126758 homologous to the known fibrinogen derived haptotactic peptides; shown to elicit activity from fibroblasts, endothelial and smooth muscle cells; for wound healing and enhancing osteogenesis/angiogenesis in vivo with/without medical implant
07/01/2004US20040126468 Food or edible material and beverages: processes, compositions, and products
07/01/2004US20040126322 Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
07/01/2004US20040126321 Forming images; medical diagnosis; ultrasonic images enhancement; suspension of gas bubbles
07/01/2004US20040126319 Screening effect of test agent; forming image; measurement; calibration; quantitative analysis
07/01/2004US20040126318 Methods, formulations and kits for monitoring and diagnosing gastric emptying and gastroparesis, and formulations for determining gastrointestinal motility
07/01/2004DE10261662A1 New 2,2'-bi(4,9-diaryl-6,7-dicyano-4,9-dihydro-1,3,4,5,8,9-hexaaza-cyclopenta(b)naphthylidene) derivatives useful as long-wavelength-emitting fluorescence dyes, e.g. for biochemical-medical diagnostics
06/2004
06/30/2004EP1432821A2 A method for the early detection of cancer
06/30/2004EP1263325A4 Embolic agents visible under ultrasound
06/30/2004EP1206287A4 Novel high viscosity embolizing compositions
06/30/2004EP1180051A4 Methods for embolizing vascular sites with an embolizing composition
06/30/2004EP0977600B1 Contrast agents targetting receptors associated with angiogenesis
06/30/2004EP0915902A4 Transgenic animals expressing artificial epitope-tagged proteins
06/30/2004CN1509267A Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II
06/30/2004CN1507835A Image-forming method for metabolic course of living body
06/29/2004US6756481 IL-23 receptor binding compositions
06/29/2004US6756407 Administering a compound which acts on a mid-brain pathway to increase blood flow in the ilio-hypogastric-pudendal arterial bed and genitalia
06/29/2004US6756210 Detecting pre-eclampsia, and pregnancy-induced hypertension by way of abnormal regulation of cytochrome p450 metabolism; enzyme inhibitors; oxidoreductases; epoxide hydrolases
06/29/2004US6756055 Administering to a mammal formulation of cationic lipids and a substance that affects angiogenesis; allowing formulation to associate with angiogenic endothelial cells of an angiogenic blood vesselsuch that it enters cells
06/29/2004US6756032 Method to enhance and/or prolong the effects of a primary challenge to a responsive system with a secondary challenge
06/29/2004CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas)
06/24/2004WO2004053504A2 Particles for imaging cells
06/24/2004WO2004053093A2 Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating
06/24/2004WO2004052407A1 Ultrasound contrast using halogenated xanthenes
06/24/2004WO2004024883A3 PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE
06/24/2004WO2004017922A3 Keto cannabinoids with therapeutic indications
06/24/2004WO2004010953A3 Implantable artificial organ devices
06/24/2004WO2003106627A3 Cancer-linked gene as target for chemotherapy
06/24/2004US20040123334 Methods of treating neurodegenerative diseases
06/24/2004US20040122443 Tattoo method and system for medical and surgical applications
06/24/2004US20040121022 Culture media and methods of making and using culture media
06/24/2004US20040120894 Rodenticide and method of screening
06/24/2004US20040120893 human monoclonal antibody fragment (Fab), cloned by phage display that binds specifically to oxidized forms of low density lipoproteins (OxLDL) and not native LDL; use of the antibody for methods of diagnosis and treatment of atherosclerosis
06/24/2004CA2505975A1 Ultrasound contrast using halogenated xanthenes
06/23/2004EP1430130A2 Nucleic acid-associated proteins
06/23/2004EP1430071A1 Secreted and cell surface genes expressed in benign and malignant colorectal tumors
06/23/2004EP1429811A1 Theurapeutic tropane compounds
06/23/2004EP1429806A2 Extracellular massengers
06/23/2004EP1429797A2 Diagnosis and treatment of malignant neoplasms
06/23/2004EP1429785A1 Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier
06/23/2004EP1429783A2 Multi-use multimodal imaging chelates
06/23/2004EP1429733A1 Preparation of microparticles
06/23/2004EP1429600A2 An invertebrate animal model with alzheimer-like pathology for screening and testing molecules
06/23/2004EP0785804B1 Liposomal agents
06/23/2004CN1154494C Adenosine A3 receptor modulators
06/22/2004US6754521 Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent
06/22/2004US6753160 Method of using metaloporphyrins for treatment of arteriosclerotic lesions
06/22/2004US6753006 Paclitaxel-containing formulations
06/22/2004US6752981 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to the phosphorus in the c3n2p or c3o2p ring
06/17/2004WO2004051265A2 Fish disease models and uses thereof
06/17/2004WO2004050698A2 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy
06/17/2004WO2004017907A3 Blood clot-targeted nanoparticles
06/17/2004WO2004016156A3 Dynamic hepatic recycling glucose tolerance test
06/17/2004WO2003033648A3 Imaging the activity of extracellular proteases in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases
06/17/2004US20040116824 Evaluation or diagnostic kit
06/17/2004US20040116806 Biopsy site marker and process and apparatus for applying it
06/17/2004US20040116703 Central nervous system disorders, nicotinic acetylcholine receptors; endocrine diseases; antiinflammatory agents; analgesics; drug dependency; skin disorders; Alzheimer's and Parkinson's disease
06/17/2004US20040115433 Mixture of hydrophobic polymer core and nanoparticles; immobilization
06/17/2004US20040115239 implant with functional layer comprises particles having a structure substituted with a functional group, wherein the functional group is adapted to modify a property of the device making it more biocompatible
06/17/2004US20040115164 Soft filament occlusive device delivery system
06/17/2004US20040115132 Having chemical switch triggering release in target site of soluble active material; controlling size and contents; high loading capacity; facilitating aggregation and crystallization
06/17/2004US20040115131 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
06/17/2004US20040115126 Expressing chimeric, bioluminescent material in cell organ or tissue and imaging; screening for DNA damage, putative carcinogens, cell growth modulation, ubiquitin-proteosome pathway
06/17/2004CA2506734A1 Fish disease models and uses thereof
06/16/2004EP1427841A2 Nucleic acid-associated proteins
06/16/2004EP1427462A1 Method for inducing selectively suppressed immune response